Support Common Dreams Today
Journalism that is independent, non-profit, ad-free, and 100% reader-supported.
#
For Immediate Release
November, 25 2013, 12:15pm EDT
Contact:
ASA Media Liaison Kris Hermes 510-681-6361
Â
Report: Medical Marijuana States Already in Compliance with Federal Enforcement Guidelines
Patient advocates call on Congress to adopt binding changes to new federal policy
WASHINGTON
Medical marijuana advocates Americans for Safe Access (ASA) issued a report today that analyzes the Obama Administration's latest enforcement guidelines for federal prosecutors in states that regulate medical marijuana distribution. The report, "Third Time the Charm? State Laws on Medical Cannabis Distribution and Department of Justice Guidance on Enforcement," shows that states have already enacted regulations that meet federal concerns, and some would have stronger regulations if it were not for federal threats that disrupted the legislative process. The report concludes with recommendations for how federal and state legislators can protect patients and harmonize state and federal policies.
Medical marijuana patients greeted the Department of Justice (DOJ) memo issued August 31st by U.S. Deputy Attorney General James Cole with cautious optimism. The memo is the third from the Obama Administration that attempts to rein in federal prosecutors in states that allow for regulated distribution of marijuana. The first memo, issued in October 2009 by Cole's predecessor, then-Deputy Attorney General David Ogden, did not stop various federal prosecutors from attempting to thwart the implementation of several state medical marijuana laws. A report issued by ASA earlier this year put the cost of federal interference with state medical marijuana programs at more than $300 million.
"We hope the latest federal policy on marijuana will compel the Obama Administration to make good on its promises to stop wasting taxpayer money on undermining duly enacted state laws," said ASA Executive Director Steph Sherer. "With almost 40 percent of Americans living in states that permit medical marijuana, it's time for the federal government to resolve the conflict between its outdated policies and the growing number of compassionate state laws."
The ASA report released today is not an endorsement of the latest DOJ guidelines. "Non-binding memos are not the solution," the report says. "As patient advocates, we are hopeful that this latest policy will act as a stepping-stone for change in federal law and facilitate states enacting laws that regulate medical cannabis while serving the needs of their patient populations." In the meantime, advocates argue that by default the federal government should defer to local or state officials if violations of the law occur.
The ASA report recommends that state legislators use the 2013 Cole memo as a guide when developing production and distribution regulations, while avoiding unnecessarily restrictive policies that fail to meet the needs of patients. The report also urges lawmakers to recognize that all three DOJ directives maintain that cultivation by individual patients is not a federal enforcement concern, giving the green light for state legislators to preserve or adopt patient cultivation rules.
The report also recommends that Congress make short and long-term policy changes to ensure respect for state laws and protection for patients and their providers. The report urges federal legislators to restrict how DOJ funds are spent on enforcement in medical marijuana states until the DOJ can determine what "metrics" to use in evaluating compliance with their enforcement priorities. As a long-term solution, the report asks Congress to adopt HR 689, which would reclassify marijuana for medical use.
Further information:
ASA report, "Third Time the Charm? State Laws on Medical Cannabis Distribution and Department of Justice Guidance on Enforcement:"
https://www.AmericansForSafeAccess.org/dojwhitepaper
Americans for Safe Access is the nation's largest organization of patients, medical professionals, scientists and concerned citizens promoting safe and legal access to cannabis for therapeutic use and research.
LATEST NEWS
'Deeply Sinister': Emails Reveal Big Pharma Pushed Twitter to Silence Vaccine Equity Voices
"At a time when online mobilizations were one of the few forms of protest available to the public, Twitter was seemingly asked to shield the powerful from criticism," said one campaigner. "That should worry all those who care about accountability."
Jan 16, 2023
Drugmaker BioNTech and the German government pushed Twitter to "hide" posts by activists calling on Big Pharma to temporarily lift patents on Covid-19 vaccines—a move which would have given people the Global South greater access to the lifesaving inoculations, a report published Monday by The Intercept revealed.
Twitter lobbyist Nina Morschhaeuser "flagged the corporate accounts of Pfizer, BioNTech, Moderna, and AstraZeneca for her colleagues to monitor and shield from activists," according to The Intercept's Lee Fang. An email from Morschhaeuser said the German Federal Office for Information Security also contacted Twitter on behalf of BioNTech, whose spokesperson, Jasmina Alatovic, asked the social media giant to "hide" activist tweets targeting her company's account for two days.
Morschhaeuser, meanwhile, requested that colleagues track the hashtags #PeoplesVaccine—a movement for the temporary lifting of patent protections—and #JoinCTAP, a reference to the World Health Organization's Covid-19 Technology Access Pool. Morschhaeuser further warned that the advocacy group Global Justice Now shared an online signup form for a December 2020 People's Vaccine Day of Action.
"The allegations in this article suggest that government and industry tried to silence legitimate criticism during a crisis," Maaza Seyoum, Global South convener at the People's Vaccine Alliance, said in a statement Monday. "At a time when online mobilizations were one of the few forms of protest available to the public, Twitter was seemingly asked to shield the powerful from criticism. That should worry all those who care about accountability."
\u201c\ud83d\udce2 REACTION: German government and @BioNTech_Group asked Twitter to censor vaccine equity critics.\n\nNew #TwitterFiles piece by @lhfang shows how they worked to silence activists demanding a #PeoplesVaccine\n\nRead our reaction: https://t.co/VyaSBIbWnS\n\n1/\u201d— The People's Vaccine (@The People's Vaccine) 1673889107
Global Justice Now director Nick Dearden also noted the troubling timing of BioNTech's censorship request during a period of global pandemic lockdowns.
"To try and stifle digital dissent during a pandemic, when tweets and emails are some of the only forms of protest available to those locked in their homes, is deeply sinister," he told The Intercept.
Fang writes:
It is not clear to what extent Twitter took any action on BioNTech's request. In response to Morschhaeuser's inquiry, several Twitter officials chimed in, debating what action could or could not be taken. Su Fern Teo, a member of the company's safety team, noted that a quick scan of the activist campaign showed nothing that violated the company's terms of service, and asked for more examples to "get a better sense of the content that may violate our policies."
But it shows the extent to which pharmaceutical giants engaged in a global lobbying blitz to ensure corporate dominance over the medical products that became central to combating the pandemic. Ultimately, the campaign to share Covid vaccine recipes around the world failed.
While U.S. President Joe Biden in 2021 heeded activists' calls and joined most of the Global South in backing a Trade-Related Aspects of Intellectual Property Rights (TRIPS) waiver at the World Trade Organization, most rich nations—including Germany—oppose the policy and have, along with Big Pharma, fought to thwart it.
"If the German government wants to show that it is now willing to side with public health over private profit, it must change its approach to pandemic response," Seyoum asserted. "That means backing efforts at the World Trade Organization to improve access to generic Covid-19 medicines and treatments, supporting the World Health Organization's mRNA Hub in South Africa, and standing up to corporate interests in negotiations over a Pandemic Treaty."
Keep ReadingShow Less
Outrage After Kerry Backs UAE Oil Exec as President of UN Climate Summit
Critics rebuke U.S. climate envoy for calling Sultan al-Jaber a "terrific choice."
Jan 16, 2023
Progressives on Monday reacted with outrage and disbelief after U.S. climate envoy John Kerry backed the appointment of Sultan al-Jaber to lead the the United Nations' annual conference on the climate emergency, saying the CEO of the United Arab Emirates' state-run oil company was not only qualified to preside over the summit, but that his background strengthened the case for his presidency.
As Common Dreamsreported last week, the UAE named al-Jaber as president of the 28th United Nations Framework Convention on Climate Change (COP28), scheduled to begin in November—a decision that was met with scorn from campaigners as al-Jaber is heads the Abu Dhabi National Oil Company (ADNOC) and a renewable energy firm in which ADNOC holds a 24% stake.
"I think that Dr. Sultan al-Jaber is a terrific choice because he is the head of the company. That company knows it needs to transition," Kerry told the Associated Press Sunday, despite the fact that scientists and advocates across the globe have also known for decades that policymakers must lead a rapid transition away from oil and gas-generated energy. "He knows—and the leadership of the UAE is committed to transitioning."
Advocates have warned that the UAE has not made clear how it plans to reach its stated goal of being carbon neutral by 2050, especially as it plans to increase production of crude oil by a million barrels per day.
The UAE is expected to become "the third largest expander of oil and gas production" between 2023 and 2025 as ADNOC embarks on the second-largest expansion of oil production of any company in the world, locking in more than 2.7 gigatonnes of CO2 emissions.
But when asked by Sky News Arabia about whether al-Jaber would have a conflict of interest at the conference, where leaders are expected to be pushed to take significant emissions-reduction steps, Kerry dismissed the concern.
"That's a first blush, very simplistic way to look at this," Kerry said, adding that "the only way we will meet this crisis and protect our citizens and build an economy for the future, is by reducing emissions."
Putting the ADNOC executive—who is also the UAE's climate enjoy and minister of industry and technology—in charge of COP28 drew comparisons from Progressive International leader Yanis Varoufaki to naming "a jihadist to oversee religious tolerance" or "a Nazi to oversee racial harmony."
"What could go wrong?" labor historian Erik Loomis asked sardonically.
\u201cJeffrey Dahmer placed to oversee anti-cannibalism commission. \n\nhttps://t.co/D7Yyz2MMAw\u201d— Erik Loomis (@Erik Loomis) 1673888060
COP28 will follow the two most recent international climate conferences, held in Glasgow, Scotland and Sharm el-Sheikh, Egypt, where hundreds of fossil fuel lobbyists were in attendance and policymakers failed to hammer out a final agreement requiring countries to phase out oil, coal, and gas extraction.
Kerry toldSky News Arabia that the UAE was not "involved in changing" the outcome of the COP26 and COP27 talks.
The former secretary of state acknowledged that there would be "a level of scrutiny" aimed at al-Jaber's appointment.
"And I think that's going to be very constructive," he told the AP. "It's going to help people, you know, stay on the line here. I think this is a time, a new time of accountability."
Acknowledging Kerry's negotiating of the Paris climate agreement in 2015—which despite its many flaws and shortcomings represents the strongest global pact ever reached on the issue—Leo Roberts of the climate think tank E3G said on social media that the U.S. politician's endorsement of el-Jaber represents "a really rather spectacular fall from grace."
Keep ReadingShow Less
Tens of Thousands March in Madrid to 'Stop Privatization' of Healthcare System
"I am Ayuso's plan for the emergency ward," said one demonstrator dressed as the Grim Reaper.
Jan 16, 2023
Tens of thousands marched in Madrid, Spain on Sunday to stop the right-wing regional government's ongoing attack on the public healthcare system.
"Cutting public health is criminal!" demonstrators chanted as they held placards against the push for privatization and cuts.
\u201cTens of thousands of health workers took to the streets of Madrid on Sunday to lodge their protests against what they consider an erosion of public health infrastructure.\n\nhttps://t.co/asGkvSgAle\u201d— DW Europe (@DW Europe) 1673869377
According to the Associated Press:
Carrying homemade signs with slogans that translated into English as "S.O.S. Public Healthcare" snd "Stop Privatization," the marchers clamored against staff shortages and criticized what they consider the favoritism shown by regional authorities toward private health care providers.
The event was the latest in a series of protest actions, including strikes, by Madrid’s public health workers against the capital region’s government, which is led by Popular Party heavyweight Isabel Ayuso.
The unions that organized Sunday's demonstration said Madrid spends the least amount per capita on primary health care of any Spanish region even though it has the highest per capita income. They claim that for every 2 euros spent on health care in Madrid, one ends up in the private sector.
"We have about 40 or 50 patients per day and can give them about six minutes each," Ana Encinas, a doctor who has worked in primary care in the nation's capital for 37 years, toldReuters. "The problem is that they do not allow us to give proper care to patients."
One protester in the crowd—led by doctors, nurses, labor groups, and other defenders of public health—was dressed as the Grim Reaper and held a sign that said: "I am Ayuso's plan for the emergency ward."
Keep ReadingShow Less
Most Popular
SUPPORT OUR WORK.
We are independent, non-profit, advertising-free and 100%
reader supported.
reader supported.